Ivantis Company
%20.jpg)
Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development for the treatment of other debilitating diseases within ophthalmology.
Investors
.png)
Investors Number:
16
Technology:
P4 Medicine
Total Funding:
$132.4M
Founded Date:
2007-01-01
Headquarters:
Irvine, California, United States
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Last Funding Type:
Series C
Investor Type:
For Profit
Funding Status:
Late Stage Venture
Industry:
Health Care, Health Diagnostics, Medical Device